Literature DB >> 22904235

Republished: pathogenesis and diagnosis of myocarditis.

Chantal Elamm1, Delisa Fairweather, Leslie T Cooper.   

Abstract

Acute myocarditis is an inflammatory disease of the heart muscle that may progress to dilated cardiomyopathy and chronic heart failure. A number of factors including the sex hormone testosterone, components of innate immunity, and profibrotic cytokines have been identified in animal models as important pathogenic mechanisms that increase inflammation and susceptibility to chronic dilated cardiomyopathy. The clinical presentation of acute myocarditis is non-specific and mimics more common causes of heart failure and arrhythmias. Suspected myocarditis is currently confirmed using advanced non-invasive imaging and histopathologic examination of heart tissue. However, the diverse presentations of myocarditis and the lack of widely available, safe, and accurate non-invasive diagnostic tests remain major obstacles to early diagnosis and population based research. Recent advances in the understanding of disease pathogenesis described in this review should lead to more accurate diagnostic algorithms and non-invasive tests.

Entities:  

Year:  2012        PMID: 22904235      PMCID: PMC5813801          DOI: 10.1136/postgradmedj-2012-301686rep

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  81 in total

1.  Biomarkers in heart failure.

Authors:  Wei-Chung Chen; Kimberly D Tran; Alan S Maisel
Journal:  Heart       Date:  2010-02       Impact factor: 5.994

2.  Interleukin-17A is dispensable for myocarditis but essential for the progression to dilated cardiomyopathy.

Authors:  G Christian Baldeviano; Jobert G Barin; Monica V Talor; Sachin Srinivasan; Djahida Bedja; Dongfeng Zheng; Kathleen Gabrielson; Yoichiro Iwakura; Noel R Rose; Daniela Cihakova
Journal:  Circ Res       Date:  2010-04-08       Impact factor: 17.367

3.  Tumor necrosis factor-alpha and interleukin-1beta synergistically depress human myocardial function.

Authors:  B S Cain; D R Meldrum; C A Dinarello; X Meng; K S Joo; A Banerjee; A H Harken
Journal:  Crit Care Med       Date:  1999-07       Impact factor: 7.598

4.  Electrocardiography of myocarditis revisited: clinical and prognostic significance of electrocardiographic changes.

Authors:  T Morgera; A Di Lenarda; L Dreas; B Pinamonti; F Humar; R Bussani; F Silvestri; D Chersevani; F Camerini
Journal:  Am Heart J       Date:  1992-08       Impact factor: 4.749

5.  Cardiac troponin T in patients with clinically suspected myocarditis.

Authors:  B Lauer; C Niederau; U Kühl; M Schannwell; M Pauschinger; B E Strauer; H P Schultheiss
Journal:  J Am Coll Cardiol       Date:  1997-11-01       Impact factor: 24.094

6.  Transcriptomic biomarkers for the accurate diagnosis of myocarditis.

Authors:  Bettina Heidecker; Michelle M Kittleson; Edward K Kasper; Ilan S Wittstein; Hunter C Champion; Stuart D Russell; Ralph H Hruban; E Rene Rodriguez; Kenneth L Baughman; Joshua M Hare
Journal:  Circulation       Date:  2011-03-07       Impact factor: 29.690

7.  Interferon-gamma protects against chronic viral myocarditis by reducing mast cell degranulation, fibrosis, and the profibrotic cytokines transforming growth factor-beta 1, interleukin-1 beta, and interleukin-4 in the heart.

Authors:  DeLisa Fairweather; Sylvia Frisancho-Kiss; Susy A Yusung; Masheka A Barrett; Sarah E Davis; Shannon J L Gatewood; Dolores B Njoku; Noel R Rose
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

8.  Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980-2006.

Authors:  Barry J Maron; Joseph J Doerer; Tammy S Haas; David M Tierney; Frederick O Mueller
Journal:  Circulation       Date:  2009-02-16       Impact factor: 29.690

9.  The Myocarditis Treatment Trial: design, methods and patients enrollment.

Authors:  E A Hahn; V L Hartz; T E Moon; J B O'Connell; A Herskowitz; B M McManus; J W Mason
Journal:  Eur Heart J       Date:  1995-12       Impact factor: 29.983

Review 10.  Antibody responses in parvovirus B19 infected patients.

Authors:  Susanne Modrow; Simone Dorsch
Journal:  Pathol Biol (Paris)       Date:  2002-06
View more
  4 in total

1.  Persistent Cardiac Magnetic Resonance Imaging Features of Myocarditis Detected Months After COVID-19 Infection.

Authors:  Basel Abdelazeem; Mariem Borcheni; Saed Alnaimat; Sagar Mallikethi-Reddy; Abdulbaset Sulaiman
Journal:  Cureus       Date:  2021-04-01

2.  Relationship between echocardiographic characteristics and cardiac biomarkers during long-distance trail running.

Authors:  Romain Jouffroy; Hélène Hergault; Juliana Antero; Antoine Vieillard Baron; Nicolas Mansencal
Journal:  Front Cardiovasc Med       Date:  2022-08-16

Review 3.  Toll-Like Receptors: Are They Taking a Toll on the Heart in Viral Myocarditis?

Authors:  Kasper Favere; Matthias Bosman; Karin Klingel; Stephane Heymans; Sophie Van Linthout; Peter L Delputte; Johan De Sutter; Hein Heidbuchel; Pieter-Jan Guns
Journal:  Viruses       Date:  2021-05-27       Impact factor: 5.048

Review 4.  Cardiovascular consequences of viral infections: from COVID to other viral diseases.

Authors:  Heinz-Peter Schultheiss; Christian Baumeier; Heiko Pietsch; C-Thomas Bock; Wolfgang Poller; Felicitas Escher
Journal:  Cardiovasc Res       Date:  2021-11-22       Impact factor: 10.787

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.